These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10777378)

  • 21. Cyproheptadine in the treatment of autistic disorder: a double-blind placebo-controlled trial.
    Akhondzadeh S; Erfani S; Mohammadi MR; Tehrani-Doost M; Amini H; Gudarzi SS; Yasamy MT
    J Clin Pharm Ther; 2004 Apr; 29(2):145-50. PubMed ID: 15068403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secretin and autism: the role of cysteine.
    Connors SL; Crowell DE
    J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):795-6. PubMed ID: 10405495
    [No Abstract]   [Full Text] [Related]  

  • 23. A double-blind, placebo-controlled crossover study investigating the effect of porcine secretin in children with autism.
    Corbett B; Khan K; Czapansky-Beilman D; Brady N; Dropik P; Goldman DZ; Delaney K; Sharp H; Mueller I; Shapiro E; Ziegler R
    Clin Pediatr (Phila); 2001 Jun; 40(6):327-31. PubMed ID: 11824175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lack of benefit of intravenous synthetic human secretin in the treatment of autism.
    Molloy CA; Manning-Courtney P; Swayne S; Bean J; Brown JM; Murray DS; Kinsman AM; Brasington M; Ulrich CD
    J Autism Dev Disord; 2002 Dec; 32(6):545-51. PubMed ID: 12553591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effectiveness of secretin in the management of autism.
    Kern JK; Espinoza E; Trivedi MH
    Expert Opin Pharmacother; 2004 Feb; 5(2):379-87. PubMed ID: 14996634
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autism and autism spectrum disorders: diagnostic issues for the coming decade.
    Volkmar FR; State M; Klin A
    J Child Psychol Psychiatry; 2009 Jan; 50(1-2):108-15. PubMed ID: 19220594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Repeated doses of porcine secretin in the treatment of autism: a randomized, placebo-controlled trial.
    Roberts W; Weaver L; Brian J; Bryson S; Emelianova S; Griffiths AM; MacKinnon B; Yim C; Wolpin J; Koren G
    Pediatrics; 2001 May; 107(5):E71. PubMed ID: 11331721
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Secretin is an ineffective treatment for pervasive developmental disabilities: a review of 15 double-blind randomized controlled trials.
    Sturmey P
    Res Dev Disabil; 2005; 26(1):87-97. PubMed ID: 15590241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Secretin for the treatment of autism.
    McQueen JM; Heck AM
    Ann Pharmacother; 2002 Feb; 36(2):305-11. PubMed ID: 11847953
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RG-1068 RepliGen.
    Wheeler G
    Curr Opin Investig Drugs; 2003 Jan; 4(1):66-71. PubMed ID: 12625032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comments on "Secretin and autism: a two-part clinical investigation" by M.G. Chez et al.
    Rimland B
    J Autism Dev Disord; 2000 Apr; 30(2):95; discussion 97-8. PubMed ID: 10832773
    [No Abstract]   [Full Text] [Related]  

  • 32. Are we in the midst of an autism epidemic? A review of prevalence data.
    Kippes C; Garrison CB
    Mo Med; 2006; 103(1):65-8. PubMed ID: 16579308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The factor structure of autistic traits.
    Constantino JN; Gruber CP; Davis S; Hayes S; Passanante N; Przybeck T
    J Child Psychol Psychiatry; 2004 May; 45(4):719-26. PubMed ID: 15056304
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Secretin in autism.
    Perry R; Bangaru BS
    J Child Adolesc Psychopharmacol; 1998; 8(4):247-8. PubMed ID: 10214929
    [No Abstract]   [Full Text] [Related]  

  • 35. Relationship between age of recognition of first disturbances and severity in young children with autism.
    Baghdadli A; Picot MC; Pascal C; Pry R; Aussilloux C
    Eur Child Adolesc Psychiatry; 2003 Jun; 12(3):122-7. PubMed ID: 12768459
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risperidone in the treatment of autistic Thai children under 4 years of age.
    Boon-Yasidhi V; Tarugsa J; Suwanwattana C; Soising L
    J Med Assoc Thai; 2002 Aug; 85 Suppl 2():S784-9. PubMed ID: 12403261
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comment: secretin for autism: unproven treatment or ineffective treatment?
    Heisler MA; Guidry JR
    Ann Pharmacother; 2002; 36(7-8):1294-5; author reply 1295. PubMed ID: 12086571
    [No Abstract]   [Full Text] [Related]  

  • 38. Drug discovery in autism: the need for a developmental context.
    Willemsen-Swinkels SH; Buitelaar JK
    Drug Discov Today; 2004 Jun; 9(11):473. PubMed ID: 15149620
    [No Abstract]   [Full Text] [Related]  

  • 39. Multiple doses of secretin in the treatment of autism: a controlled study.
    Sponheim E; Oftedal G; Helverschou SB
    Acta Paediatr; 2002; 91(5):540-5. PubMed ID: 12113323
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Is there one autism or are there several kinds?].
    Lemay M
    Sante Ment Que; 1998; 23(1):7-18. PubMed ID: 9775951
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.